SaMD

A complete guide to Health Canada's pre-market guidance for machine learning-enabled medical devices (MLMD), published April 2026, covering predetermined change control plans (PCCP), data quality requirements, bias mitigation, lifecycle risk management, mandatory digital submissions, terms and conditions enforcement, and how Canada's approach compares to FDA and EU AI Act requirements.

How to test AI-enabled medical devices for algorithmic bias across demographic subgroups, validate fairness using statistical methods, document bias analysis for FDA 510(k) and EU MDR submissions, and implement ongoing post-market monitoring — based on FDA AI-enabled device TPLC draft guidance, EU AI Act high-risk requirements, and 2026 regulatory expectations.

How to conduct clinical evaluation for Software as a Medical Device (SaMD) — valid clinical association, analytical validation, and clinical performance under IMDRF N41, FDA requirements, and EU MDR Article 61, including generating clinical evidence without traditional clinical trials, real-world data strategies, and navigating the January 2026 FDA withdrawal of the SaMD clinical evaluation guidance.

On May 7, 2026, the EU Council and Parliament reached a provisional deal to simplify AI Act rules. This guide breaks down what changed, what the product safety exemption means for medical devices, the new compliance timelines for AI-enabled SaMD and IVDs, and what manufacturers must do now.

A methodical approach to mining FDA's AI-enabled device list and 510(k) database for predicate devices — covering technological characteristic extraction, public summary limitations, weak predicate argument avoidance, and a complete predicate evaluation matrix.

A comprehensive guide to IEC 62304 Edition 2 — the 2026 update replacing safety classes A/B/C with rigor levels, expanding scope to all health software, adding AI/ML lifecycle requirements, integrating cybersecurity, and practical compliance timelines for medical device manufacturers.

How to design and implement a drift monitoring protocol for AI-enabled imaging devices under FDA PCCP — dataset shift, scanner drift, demographic drift, performance thresholds, monitoring cadence, retraining triggers, labeling changes, and when FDA submission is still required.

A deep analysis of FDA's January 2025 draft guidance on AI-Enabled Device Software Functions — total product lifecycle approach, data management requirements, bias mitigation strategies, transparency expectations, marketing submission content, and practical steps manufacturers should take before the guidance is finalized.

Complete guide to augmented reality and virtual reality medical device regulation — FDA classification, product codes, 510(k) vs De Novo pathways, the 104 FDA-cleared AR/VR devices, surgical navigation, therapeutic VR, and human factors requirements in 2026.

How HL7 FHIR, IEEE 11073, and DICOM standards enable medical device data interoperability — including the Caliper Accelerator, CMS mandates, FDA premarket expectations, and implementation guidance for manufacturers.

How to choose between Agile and Waterfall for medical device software development under IEC 62304 — AAMI TIR45 guidance, design control mapping, hybrid models, and what auditors actually look for.

Complete guide to distinguishing SaMD, SiMD, and embedded software for medical devices — IMDRF definitions, IEC 62304 classification, FDA and EU MDR regulatory pathways, MDCG 2019-11 guidance, documentation requirements, and practical decision frameworks for medtech manufacturers.

Complete guide to FDA's January 2026 Clinical Decision Support software guidance — the four statutory criteria for non-device CDS exclusion under Section 520(o)(1)(E), device vs non-device examples, SaMD boundary decisions, enforcement discretion positions, and practical compliance strategies for digital health companies.

How to develop and implement a Predetermined Change Control Plan (PCCP) for AI-enabled medical devices under FDA's August 2025 final guidance — three mandatory components, submission strategy, real-world examples, and step-by-step implementation roadmap.

A comprehensive guide to IEC 82304-1 health software product safety — how it complements IEC 62304, product requirements, validation, cybersecurity, lifecycle management, regulatory alignment with FDA/EU MDR, and practical implementation for SaMD and health app manufacturers.

Everything medical device manufacturers need to know about Software Bill of Materials — FDA cyber device requirements, NTIA minimum elements, SPDX vs CycloneDX formats, VEX integration, tools, and post-market management strategies.

A data-driven analysis of the AI medical device investment boom — covering the Medtronic/CathWorks deal, Zimmer Biomet/Monogram acquisition, HistoSonics' $2.25B valuation, record FDA AI clearances, and how AI now drives 55% of all health tech funding in 2025-2026.

Complete guide to digital health and AI medical device regulation across MENA — SFDA MDS-G27 guidance on digital health products (SaMD, mHealth, DTx, AI/ML, telemedicine, wearables, VR/AR), UAE EDE AI registration frameworks and National AI Strategy 2031, Turkey TITCK software medical device classification and exclusion list, Israel AMAR software requirements, and practical compliance strategies for each market.

The complete guide to South Korea's Digital Medical Products Act — product categories (digital medical devices, digital-convergence pharmaceuticals, digital health-support devices), MFDS classification, approval pathways, AI/ML requirements, cybersecurity obligations, QMS, and labeling requirements.

A complete guide to the regulatory pathway for digital therapeutics — including FDA clearance strategies (510(k), De Novo, PMA), EU MDR classification, Germany's DiGA reimbursement program, approved DTx products, clinical evidence requirements, and what's changing in 2026.